LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.279
+0.029 (2.31%)
At close: May 12, 2025, 4:00 PM
1.260
-0.019 (-1.48%)
After-hours: May 12, 2025, 5:39 PM EDT
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $33.64 million as of May 12, 2025. Its market cap has decreased by -53.30% in one year.
Market Cap
33.64M
Enterprise Value
-37.65M
1-Year Change
-53.30%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $33.64M, a decrease of -91.15%. That is a compound annual growth rate of -44.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 32.88M | 31.47% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |